Linda Johnson

MADRID, SPAIN – 2021/07/21: In this photo illustration vials of Moderna vaccine (COVID-19 mRNA, nucleoside modified) with a syringe for coronavirus treatment. Spain has exceeded 50% of the population vaccinated with the full schedule against COVID-19. (Photo Illustration by Marcos del Mazo/LightRocket via Getty Images)

Moderna will expand its child COVID vaccine study to better detect side effects

By Matthew Perrone, Linda Johnson, and others

FILE – In this Wednesday, Oct. 7, 2020, file photo, a Phase 3 Novavax coronavirus vaccine trial volunteer is given an injection at St George’s University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant, File)

Novavax COVID-19 vaccine is about 90% effective, according to late-stage study

By The Associated Press and Linda Johnson

J&J’s vaccine mix-up started at supply chain firm with string of FDA citations

By Richard Lardner, Linda Johnson, and others